Cargando…
COVID-19-vaccine-Gamaleya-National-Research-Center-of-Epidemiology-and-Microbiology: Seropositive rheumatoid arthritis: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8732147/ http://dx.doi.org/10.1007/s40278-022-07893-x |
Ejemplares similares
-
COVID-19 vaccine Gamaleya National Research Center of Epidemiology and Microbiology: Myocarditis: case report
Publicado: (2022) -
COVID-19-vaccine-Gamaleya-National-Research-Center-of-Epidemiology-and-Microbiology: Acute disseminated encephalomyelitis: case report
Publicado: (2021) -
Covid-19-vaccine-gamaleya-national-research-center-of-epidemiology-and-microbiology: Neuromyelitis optica spectrum disorder: case report
Publicado: (2022) -
Rituximab/COVID-19-vaccine Gamaleya National Research Center of Epidemiology and Microbiology: Hemiplegia, ataxia and poor immunisation: case report
Publicado: (2021) -
Covid-19-vaccine-gamaleya-national-research-center-of-epidemiology-and-microbiology/fexofenadine: Eczematous lesions and lack of efficacy: case report
Publicado: (2022)